Tue.Dec 07, 2021

article thumbnail

A serial biotech entrepreneur launches his next startup with high-dollar backing

Bio Pharma Dive

Founded and led by Gary Glick, Odyssey Therapeutics has raised $218 million in an initial fundraising round for its cancer and inflammatory disease drug research.

Drugs 352
article thumbnail

Is artificial intelligence the best tool for drug discovery?

Outsourcing Pharma

According to a leader from Cytoreason, AI isnât necessarily the best or only tool suited to discover new and novel therapiesâit might take a human touch.

Drugs 144
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Vaccine from Medicago, GSK protective against COVID-19 in large study

Bio Pharma Dive

The vaccine, which Medicago plans to soon submit to Canadian regulators, would be the first of its type, though supply appears likely to be limited.

article thumbnail

CHMP recommend approval for Roche’s COVID-19 therapy

Pharma Times

According to clinical data, Roche’s new COVID-19 treatment Actemra/RoActemra lowered mortality risk in critically ill adult patients.

119
119
article thumbnail

Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

article thumbnail

AstraZeneca wagers $200M on Ionis' next chance at a rare disease drug

Bio Pharma Dive

The alliance follows AstraZeneca's buyout of Alexion last year and puts the British drugmaker in competition with Alnylam, Bridgebio and several others.

Drugs 311
article thumbnail

Plant-based COVID-19 vaccine candidate reports positive Phase 3 results

BioPharma Reporter

Medicago and GSKâs plant-based COVID-19 vaccine candidate has reported an overall efficacy rate of 71% in Phase 3 trials: with the final regulatory submission for the vaccine to be filed with Health Canada shortly.

More Trending

article thumbnail

Mind the gap: Are you delivering what HCPs value or what you want them to have?

pharmaphorum

Since the onset of the Covid-19 pandemic, life science companies have acted quickly to address the evolving digital needs of healthcare professionals, with mixed success (see graph 1). In the age of information overload, we all know that it is essential to add ‘value’ if we are to cut through the noise. And therein lies an issue. In a recent study by EPG Health, pharma respondents voted ‘providing real value’ the top challenge (of 23) related to digital Health Care Provider (HCP) engagement.

article thumbnail

Study Calls Out Lack of Reproducibility in Cancer Research

BioSpace

?Known as the Reproducibility Project: Cancer Biology, it spent eight years replicating experiments from high-impact cancer biology papers published between 2010 and 2012.

Research 103
article thumbnail

Belgian cancer vaccine biotech raises over $20m in funding round, attracts more Asian investors

BioPharma Reporter

PDC*line Pharma, a clinical stage biotech company developing cancer vaccines, has completed its Series B2 round of financing, raising a total of â17.5m (US$20.3m) with Belgian and South-Korean investors.

article thumbnail

Pfizer Reassures with Booster Data After Reports of Lowered Omicron Protection

BioSpace

Pfizer's preliminary laboratory studies have shown that the third booster dose increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

How Hydra animals regenerate their own heads

Scienmag

A new paper in Genome Biology and Evolution, published by Oxford University Press, maps out for the first time how Hydra, which are a group of small aquatic animals, can regenerate their own heads by changing the way that their genes are regulated, known as epigenetics. Credit: David Plachetzki A new paper in Genome Biology […].

Genome 96
article thumbnail

LAG-3 Pioneer Frédéric Triebel Discusses Its Potential in Immunotherapy

BioSpace

LAG-3 is a priority focus in cancer immunotherapy because its inhibition has the potential to make PD-1 inhibitors work in more patients.

117
117
article thumbnail

UK study shows mixing Pfizer and AstraZeneca COVID-19 vaccines with Moderna elicits better immune response

Pharma Times

Results show support in favour of heterologous dosing which may help to advance vaccination programmes in poorer countries.

article thumbnail

Former Martin Shkreli Company Vyera Settles Federal Lawsuit for $40 Million

BioSpace

Vyera Pharmaceuticals agreed to pay $40 million to settle federal allegations to radically increase the price of toxoplasmosis drug Daraprim and prevent generic competition.

Drugs 98
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Efficient coding: How the brain optimizes allocation of resources

Scienmag

A collaboration between SISSA and the University of Pennsylvania indicates the existence of an efficient process of sensory coding in rats, suggesting a general principle for optimal use of computational resources. The study, published in eLife, paves the way for an understanding of the underlying neuronal mechanisms behind this efficiency and for the development of […].

article thumbnail

Avistone Scores $200 Million to Target Molecular Drivers of Cancer

BioSpace

On Wednesday, clinical-stage biotech Avistone Pharmaceuticals announced that it has raised more than $200 million of financial backing to support its business combination with Pearl Biotechnology.

97
article thumbnail

CityU physicists discovered special transverse sound wave

Scienmag

Can you imagine sound travels in the same way as light does? A research team at City University of Hong Kong (CityU) discovered a new type of sound wave: the airborne sound wave vibrates transversely and carries both spin and orbital angular momentum like light does. The findings shattered scientists’ previous beliefs about the sound […].

article thumbnail

Report: Biogen Eyes Massive Layoffs in Wake of Disappointing Aduhelm Rollout

BioSpace

The company could lay off as many as 1,000 employees as it continues to deal with the controversial treatment.

114
114
article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Newly discovered fish songs demonstrate reef restoration success

Scienmag

Newly discovered fish songs demonstrate reef restoration success Credit: The Ocean Agency Newly discovered fish songs demonstrate reef restoration success Whoops, croaks, growls, raspberries and foghorns are among the sounds that demonstrate the success of a coral reef restoration project. Thousands of square metres of coral are being grown on previously destroyed reefs in Indonesia, […].

90
article thumbnail

With Positive Data in Hand, Neurocrine and Acadia Prepare for NDAs

BioSpace

?Neurocrine Biosciences and Acadia Pharmaceuticals posted positive top-line results from their respective Phase III trials on major neurological diseases.

Trials 98
article thumbnail

Katerina Akassoglou elected to National Academy of Inventors

Scienmag

Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes, has been named a fellow of the National Academy of Inventors (NAI). Election to NAI is the highest professional distinction given solely to academic inventors. Credit: Gladstone Institutes Katerina Akassoglou, PhD, senior investigator at Gladstone Institutes, has been named a fellow of the National Academy of Inventors […].

88
article thumbnail

Life Sciences Expansions Take Off as 2021 Wraps Up

BioSpace

Several life sciences companies and life science-focused real estate firms have announced expansion plans as 2021 comes to an end.

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

MU researchers say it’s time to clean up the Clean Water Act

Scienmag

COLUMBIA, Mo. — In 1969, the Cuyahoga River near Cleveland was so polluted that it caught fire, helping to launch the modern environmental movement and prompting Congress to pass the Clean Water Act three years later. It was one of the first laws to safeguard waterways and set national water quality standards. Credit: University of […].

article thumbnail

Newpath Commits $350 Million to Fund the Next Good Things in the Life Sciences

BioSpace

Newpath is guided by the ethos: “Do the right thing and good things will happen.

article thumbnail

Denisovans or Homo sapiens: Who were the first to settle (permanently) on the Tibetan Plateau?

Scienmag

The Tibetan Plateau has long been considered one of the last places to be populated by people in their migration around the globe. A new paper by archaeologists at the University of California, Davis, highlights that our extinct cousins, the Denisovans, reached the “roof of the world” about 160,000 years ago — 120,000 years earlier […].

84
article thumbnail

New Covid Pills Offer Hope as Omicron Looms

NY Times

Merck and Pfizer will soon debut prescription pills to treat Covid-19. And more drugs are on the way.

Drugs 88
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

UTAComNav program selected to assist veteran and military spouse businesses

Scienmag

The University of Texas at Arlington will establish the UTA Community Navigator (UTAComNav) Program with a $200,000 grant from the U.S. Small Business Administration to support veteran and military spouse businesses with entrepreneurship education, small business technical assistance, loan preparation, access to capital/capital readiness, corporate and federal contracting and networking.

84
article thumbnail

Cancer Diagnostics Company CEO is Stephen Hahn's Next Act

BioSpace

At Harbinger, Hahn will oversee the development of the Bio-AI diagnostics platform dubbed HarbingerHx, in hopes of detecting cancer in a patient before it is visible or symptomatic.

article thumbnail

Ferocious fungus

Scienmag

Dec. 7, 2021 — It’s called Armillaria ostoyae, and it’s a gnarly parasitic fungus with long black tentacles that spread out and attack vegetation with the ferocity of a movie monster. Credit: Debora Lyn Porter/University of Utah College of Engineering Dec. 7, 2021 — It’s called Armillaria ostoyae, and it’s a gnarly parasitic fungus with […].

article thumbnail

Clinical Trial Conference Offers New Solutions

Imperical Blog

I recently attended OCT New England, which was my first in-person clinical trial conference since the spring of 2020! It felt great to be with so many people from the industry. Pandemic… The post Clinical Trial Conference Offers New Solutions appeared first on Imperial Clinical Research Services Blog; Trending Topics.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.